KR20230137404A - Cbd를 사용한 수면 무호흡증의 치료 - Google Patents

Cbd를 사용한 수면 무호흡증의 치료 Download PDF

Info

Publication number
KR20230137404A
KR20230137404A KR1020237029079A KR20237029079A KR20230137404A KR 20230137404 A KR20230137404 A KR 20230137404A KR 1020237029079 A KR1020237029079 A KR 1020237029079A KR 20237029079 A KR20237029079 A KR 20237029079A KR 20230137404 A KR20230137404 A KR 20230137404A
Authority
KR
South Korea
Prior art keywords
cbd
sleep
patients
subject
dee
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237029079A
Other languages
English (en)
Korean (ko)
Inventor
조셉 팔룸보
도나 거터맨
테리 세브리
Original Assignee
지네르바 파마슈티컬스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지네르바 파마슈티컬스, 인코포레이티드 filed Critical 지네르바 파마슈티컬스, 인코포레이티드
Publication of KR20230137404A publication Critical patent/KR20230137404A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
KR1020237029079A 2021-01-28 2022-01-28 Cbd를 사용한 수면 무호흡증의 치료 Pending KR20230137404A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163142835P 2021-01-28 2021-01-28
US63/142,835 2021-01-28
PCT/IB2022/050781 WO2022162621A1 (en) 2021-01-28 2022-01-28 Treatment of sleep apnea with cbd

Publications (1)

Publication Number Publication Date
KR20230137404A true KR20230137404A (ko) 2023-10-04

Family

ID=80222209

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237029079A Pending KR20230137404A (ko) 2021-01-28 2022-01-28 Cbd를 사용한 수면 무호흡증의 치료

Country Status (11)

Country Link
US (1) US20240307418A1 (https=)
EP (1) EP4284349A1 (https=)
JP (1) JP2024505212A (https=)
KR (1) KR20230137404A (https=)
CN (1) CN116829135A (https=)
AU (1) AU2022213009A1 (https=)
CA (1) CA3206508A1 (https=)
IL (1) IL304827A (https=)
JO (1) JOP20230169A1 (https=)
MX (1) MX2023008876A (https=)
WO (1) WO2022162621A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2627344A (en) * 2022-12-16 2024-08-21 Kingdom Therapeutics Ltd Cannabinoid based therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
CA2760460C (en) 2009-04-28 2019-04-02 Alltranz Inc. Transdermal formulations of cannabidiol comprising a penetration enhancer and methods of using the same
BR112019026877A2 (pt) * 2017-06-19 2020-06-30 Zelda Therapeutics Operations Pty Ltd composições para distúrbios do sono e tratamentos do mesmo
IL278548B2 (en) * 2018-05-11 2025-07-01 Rhodes Tech Inc Pharmaceutical preparations containing dronabinol and sprays containing the same pharmaceutical preparations
WO2019224824A1 (en) * 2018-05-24 2019-11-28 To Pharmaceuticals Llc Cannabis-based compositions for the treatment of autistic spectrum disorders
BR112022004175A2 (pt) * 2019-09-17 2022-05-31 Zynerba Pharmaceuticals Inc Tratamento de encefalopatia de syngap1

Also Published As

Publication number Publication date
EP4284349A1 (en) 2023-12-06
MX2023008876A (es) 2023-09-12
CN116829135A (zh) 2023-09-29
AU2022213009A1 (en) 2023-08-17
WO2022162621A1 (en) 2022-08-04
JOP20230169A1 (ar) 2023-07-27
IL304827A (en) 2023-09-01
CA3206508A1 (en) 2022-08-04
JP2024505212A (ja) 2024-02-05
US20240307418A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
Taranto-Montemurro et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial
US12508270B2 (en) Treatment of behavioral impairment in developmental and epileptic encephalopathy
US20250213465A1 (en) Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults
US20240009210A1 (en) Cannabidiol for the Treatment of Refractory Seizures
Rahman et al. Lavender aromatherapy: Its effect on preoperative anxiety and propofol requirement for anesthesia
Takaesu et al. Effects of nasal continuous positive airway pressure on panic disorder comorbid with obstructive sleep apnea syndrome
KR20230137404A (ko) Cbd를 사용한 수면 무호흡증의 치료
WO2023200906A1 (en) Treatment of seizure disorders
Cerimele Hyperosmolar hyperglycemic state in a patient taking risperidone

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230825

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250120

Comment text: Request for Examination of Application